Leaderboards/cancer related molecular pathways

cancer related molecular pathways

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Elena Fountzilas
European University Cyprus
99
2
Apostolia M. Tsimberidou
The University of Texas MD Anderson Cancer Center
90
3
Junhui He
Guangxi University
80
4
Juying Zhou
State Ethnic Affairs Commission
70
5
Marica Rosaria Ippolito
European Institute of Oncology
60
6
Uri Ben‐David
Tel Aviv University
50
7
Jinyan Luo
Chinese Academy of Sciences
40
8
Bowen Yang
Guangzhou University of Chinese Medicine
20
9
Zhiyu Wang
Guangzhou University of Chinese Medicine
10

Rising Stars Papers

1
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors
Clinical Cancer Research|2025
41 cit.
2
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling
Cell Death and Disease|2024
34 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Muhammad Javed Iqbal
University of Sialkot
99
2
Md Entaz Bahar
Gyeongsang National University
90
3
Weiwei Cui
Shandong University
80
4
Yuen Zeng
Air Force Medical University
70
5
Shujun Huang
West China Medical Center of Sichuan University
60
6
Pan Ma
MACOM (United States)
50
7
Yong Zhang
Hebei Medical University
40
8
Francesco Facchinetti
Inserm
30
9
Olli Dufva
University of Helsinki
20
10
Na Liu
Jiangsu University
10

Emerging Leaders Papers

1
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Signal Transduction and Targeted Therapy|2023
744 cit.
2
Resistance to Selective FGFR Inhibitors in <i>FGFR-</i> Driven Urothelial Cancer
Cancer Discovery|2023
69 cit.
3
The Immunogenicity of Coxsackievirus A6 (D3a Sub‐Genotype) Virus‐Like Particle and mRNA Vaccines
Journal of Medical Virology|2025
6 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Michael F. Berger
Memorial Sloan Kettering Cancer Center
99
2
Arul M. Chinnaiyan
Computational Physics (United States)
90
3
Solange Peters
University Hospital of Lausanne
80
4
Kornélia Polyák
Harvard University
70
5
Seishi Ogawa
Kyoto University
60
6
Ziwei Huang
Thomas Jefferson University
50
7
Patrick Tan
National University of Singapore
40
8
Roger S. Lo
The University of Sydney
30
9
Jin Geng
Chinese Academy of Sciences
30
10
Pierre Laurent‐Puig
Inserm
20

All-Time Leaders Papers

1
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Annals of Oncology|2018
2.9k cit.
2
The polycomb group protein EZH2 is involved in progression of prostate cancer
Nature|2002
2.7k cit.
3
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
Genes & Development|1994
2k cit.
4
Heterogeneity in breast cancer
Journal of Clinical Investigation|2011
1k cit.
5
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Nature|2016
629 cit.
6
Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance
Nature Communications|2012
620 cit.
7
Molecular Ordering of the Cell Death Pathway
Journal of Biological Chemistry|1996
585 cit.
8
Genetic determinants of p53-induced apoptosis and growth arrest.
Genes & Development|1996
466 cit.
9
The microenvironment in breast cancer progression: biology and implications for treatment
Breast Cancer Research|2011
412 cit.
10
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
Genome biology|2014
382 cit.

Indexing cancer related molecular pathways Reagents

Citation data for reagents in this field is currently compiling.